a total of 2,558 subjects were enrolled. Endoscopic atrophic gastritis was graded by Kimura-Takemoto classification and histological atrophic gastritis was assessed by updated Sydney system. Serological assessment of atrophic gastritis was based on serum pepsinogen test. Results: The serum pepsinogen I/II ratio showed a significant decreasing nature when the extent of atrophy increased (R 2 =0.837, P＜0.001) and the cut-off value for distinguishing between presence and absence of endoscopic atrophic gastritis was 3.2. The serum pepsinogen I and pepsinogen I/II ratio were significantly lower when the histological atrophic gastritis progressed and the cut-off value was 3.0 for a diagnosis of histological atrophic gastritis. A significant correlation between endoscopic and histological atrophic gastritis was noted and the sensitivity and specificity of endoscopic diagnosis were 65.9% and 58.0% for antrum, 71.3% and 53.7% for corpus, respectively. Conclusions: The endoscopic, histological, and serological atrophic gastritis showed relatively good correlations. However, as these three methods have a limitation, a multifactorial assessment might be needed to ameliorate the diagnostic accuracy of atrophic gastritis. (J Cancer Prev 2014;19:47-55) 
INTRODUCTION
The Correa hypothesis suggested that the gastric mucosa undergoes a series of changes resulting in chronic gastritis, atrophy, intestinal metaplasia, and dysplasia, before developing into gastric cancer. 1, 2 Gastric atrophy which is included in this cascade has been regarded as a premalignant condition of gastric cancer and the risk for gastric cancer development was increased significantly with the severity of premalignant condition at initial diagnosis. 3 Thus, early identification of such precancerous lesion can lead to the early diagnosis of gastric cancer and improve patients' survival. 4 The prevalence of gastric cancer is unacceptably high in Korea. The age-standardized incidence of gastric cancer during 2010 in South Korea, as determined by the Korea National Cancer
Incidence Database was 62.3 per 100,000 person-years for men and 24.9 for women. 5 Furthermore, most cases of gastric atrophy are associated with Helicobacter pylori (H. pylori) infection, with the seroprevalence of H. pylori being still high about 54.4% among asymptomatic Korean adults in 2011. 6 A Korean health check-up program supported by Korean government is designed to detect gastric cancer by biannual endoscopic evaluation. In real clinical setting, the diagnosis of atrophic gastritis (AG) is performed by histology of biopsy specimens when atrophy is highly suspected endoscopically. However, multiple biopsies are invasive and time-consuming procedure and a few endoscopic biopsy samples could not reflect the entire extent of atrophy. Other non-invasive method to diagnosis of AG is serum pepsinogen which is referred to as "serologic biopsy". Pepsinogen (PG) I is exclusively produced by chief and mucous neck cells in the fundic glands, while PG II is secreted by these cells and also by the cells in the pyloric glands and Brunner's glands. 7 Serum PG has been found to be a marker of gastric mucosal status, including mucosal atrophy. A low PG I level and a low PG I/II ratio have been associated with severe gastric atrophy, and are frequently found in gastric cancer.
Chronic AG can be assessed endoscopically, histologically, and serologically and it is important to understand the relationships among these 3 diagnostic methods. Eshmuratov et al. 8 reported that the correlation between endoscopic and histologic diagnosis of gastric atrophy and Yang et al. 9 reported the relationship between endoscopic and serological diagnosis in Korean. However, there was no comprehensive study about these 3 methods in Korean population.
From this background, the aim of this study was to compare the diagnostic capability of each diagnostic method and to evaluate the correlations among endoscopic, histological, and serological diagnoses for the assessment of AG.
MATERIALS AND METHODS
Patients
We consecutively enrolled 2,558 subjects who visited 
Endoscopic Examination
The patients were required to fast for at least 6 hours before the endoscopic procedure. The endoscopy was performed using GIF-Q260 (Olympus Co., Tokyo, Japan) after local pharyngeal anesthesia was provided using lidocaine spray (xylocaine). Some patients demanded sedation and received 3-4 mg of intravenous midazolam.
All endoscopic investigations were performed by a single highly experienced endoscopist (N.K.) to minimize interobserver variability. The presence of gastric atrophy was decided by the well visualization of the submucosal vessel due to thinning of mucosa in the antrum and in the body, respectively. Endoscopic gastric mucosal atrophy was classified according to the Kimura-Takemoto classification. 10 In this classification, atrophic patterns are Table 1 . Baseline characteristics of the 2,558 study subjects portion of the body, respectively. In the O-1 type, the atrophic border lies between the lesser curvature and the anterior wall of the body; in O-2, the atrophic change spreads amid the anterior wall; and in O-3, the border lies between the anterior wall and the greater curvature.
Histologic Examination and H. pylori test
To determine the presence of current H. pylori infection, 10 biopsy specimens were taken for three types of H. pylori testing (histology, rapid urease testing, and culture). Two biopsy specimens were taken from the greater curvature of both the antrum and body of the stomach, respectively, and three from both the lesser curvature of the antrum and body, respectively. Among the 10 specimens, two from the antrum and two from the body were fixed in formalin, and assessed for the presence of H. pylori by modified Giemsa staining. Moreover, the degree of inflammatory cell infiltration (activity and chronic inflammation), atrophy (loss of appropriate glands), and metaplasia were determined by hematoxylin & eosin (H&E) staining by averaging the score of the biopsy specimens from the greater and lesser curvature of the stomach. The histological features of the gastric mucosa were recorded using the updated Sydney scoring system (i.e., 0=none, 1=slight, 2=moderate, and 3=marked). 11 When the specimens were not prepared well enough to correctly evaluate the full-thickness gastric mucosa due to problems such as improper fixation, inaccurate orientation, and inappropriate sections, or whenever inflammation prevented a clear distinction between non atrophic and atrophic phenotypes these samples were classified as indefinite for atrophy 12 and excluded from the enrollment in the present study.
One specimen from each, the lesser curvature of the antrum and the body was used for rapid urease testing (CLOtest, Delta West, Bentley, Australia). The result of rapid urease testing was finally read after 24 hours. Two specimens from the antrum and body were used for culture.
The antral and body biopsy specimens were evaluated separately; organisms were identified as H. pylori by Gram staining, colony morphology, and positive oxidase, catalase, and urease reactions. 13 If any one of these three H.
pylori tests was positive, the host was regarded as having an on-going H. pylori infection. 
RESULTS

Baseline characteristics of study subjects
The total number of study subjects was 2,558 (mean age 57. 
Correlation between serum PG levels and endoscopic gastric atrophy
The serum PG I/II ratio showed a significant decreasing nature when the extent of atrophy by the KimuraTakemoto classification was progressed from C-1 to O-3 (R 2 =0.837, P＜0.001) (Fig. 1) . Serum PG I levels were
significantly lower in open-type AG compared to the closed-type AG ( Fig. 2A) , however, there was no significant differences in serum PG II levels among groups (Fig. 2B) .
PG I/II ratio decreased significantly as endoscopic gastric mucosal atrophy progressed (Fig. 2C) . Receiver operator characteristic (ROC) curve revealed that the optimal PG I/II ratio cut-off value was 3.2 for distinguishing between presence and absence of endoscopic gastric mucosal atrophy, with 64.1% sensitivity and 60.2% specificity (Fig. 3) .
Correlation between serum PG levels and histologic gastric atrophy
Serum PG I level was significantly lower in the corpus gastritis and pangastritis compared to the normal or antral gastritis (Fig. 4A) . In contrast to PG I level, the PG II level showed no significant differences (Fig. 4B) . Consequently, the PG I/II ratio was significantly lower in antral, corpus
and pangastritis compared to the normal group (Fig. 4C) .
The ROC analysis of gastritis diagnosis by PG I/II ratio revealed an optimal PG I/II ratio cut-off of 3.0 for a diagnosis of histological gastritis with 63.7% sensitivity and 60.9% specificity (Fig. 5 ).
Correlation between endoscopic and histological gastric atrophy
A significant correlation was shown between endoscopic AG and histological gastric atrophy grade in antrum ( Fig.   6A ) and corpus (Fig. 6B) . The sensitivity and specificity of endoscopic diagnosis of antral AG depending on histology were 65.9% and 58.0%, respectively. The sensitivity and specificity of endoscopic diagnosis of corpus AG depending on histology were 71.3% and 53.7%, respectively (Table 2 ).
DISCUSSION
Our study showed strong correlations among the endoscopic, histological, and serological diagnoses of atrophic gastric, which has not been compared, so far. The diagnosis of histological AG is currently based on update Sydney System. 11 Updated Sydney system recommends to take at least five biopsy specimens; two from the antrum, two from the corpus and one from the angle. Takemoto in 1969. 10 The problem of diagnosis of AG by conventional endoscopy is high inter-observer variability 16 and a poor correlation with histological findings. For example, the sensitivity of absence of rugae for moderate to severe AG in the gastric corpus was 67% and the sensitivity of the presence of visible vessels for moderate to severe atrophy in the corpus was 48%. 17 In this study, the sensitivity and specificity of endoscopic atrophy based on the histological diagnosis were 66.1 and 59.5% in antrum AG and have been studied as a biomarker to select high risk group for gastric cancer. 7, 18 As AG is acknowledged to be a precancerous condition or frequently associated finding especially in case of intestinal type of gastric cancer, the decrease of PG I ≤70 ng/ml concentration and PG I/II ratio ≤3 has been widely accepted as a cut off value for gastric cancer in Japan. [19] [20] [21] Several studies have yielded conflicting results regarding the values of PG as biomarkers of AG. Broutet et al. 22 showed that only PG I/II ratio was a reliable marker of AG in the corpus with a sensitivity of 77% and a specificity of 87% at a cut-off value of 5.6. Similarly, previous Korean study showed that a PG I of ≤70 ng/ml was found to have a sensitivity of around 80% for detecting corpus AG, but was associated with very low specificity, of around 30%. 23 In contrast, a PG I/II ratio of ≤3 showed moderate sensitivity (66.8% and 67.5%, respectively) and high specificity (74.7% and 70.1%, respectively) for detecting corpus AG. 23 as the extent of AG increased, the serum PG I/II ratio decreased and thus gastric cancer ratio increased. 25 In this study, the serum pepsinogen I/II ratio showed a significant decreasing nature when the extent of atrophy progressed from C-1 to O-3.
Advantages of serum PG test include that this test can be performed simultaneously with other blood tests, can be gained as numeric values enabling a more objective evaluation, can reveal high risk group of gastric cancer to take more attention, there's no need to fasting before the test and also can be tested on pregnant women. 26, 27 However, PG II level would be decreased after the eradication therapy of H. pylori is done. Considering PG value is known to be not fluctuating throughout several years, grouping higher risk of patients for gastric cancer using PG test could be used as efficient tool for recommending those patients to receive more frequent endoscopic evaluation.
PG test is not adequate for patients who take gastric acid inhibitors or who have chronic kidney diseases showing higher PG level which is lowered after gastrectomy.
The strengths of this study are as follows: long study duration in a large cohort and a comprehensive review with a consistent cohort in a single center. Takao et al. 28 also demonstrated significant correlations between serum pepsinogen levels, endoscopic gastritis, and histological gastritis in 319 Japanese subjects. However, the sample size is relatively small compare to our study. Another strong point is that all endoscopic investigations were performed by a single highly experienced endoscopist, by which inter-observer variability was minimized and diagnostic consistency was maintained.
In conclusion, the endoscopic, histologic, and serologic atrophic gastritis showed a relatively good correlation.
However, the sensitivity and specificity of endoscopic findings and serologic results for the diagnosis of atrophic gastritis are not so high and histological diagnosis has its limitations. Thus, a multifactorial assessment might be needed to ameliorate the diagnostic accuracy of atrophic gastritis.
